Site Search
Search Results
The Future of Health Care: Achieving Health Equity in Cancer Care
... to focus on public policies that could effectively eliminate barriers that prevent patients from accessing evidence-based and innovative cancer care with an emphasis on policies and programs that address inequities in the system. Focus of the Forum The American Cancer Society and the ... goal to achieve a 40% reduction in cancer mortality in the United States by 2035. If we are to achieve that goal, we must fight to achieve health equity, the just and fair opportunity for everyone to prevent, find, treat and survive cancer – regardless of how much money they make, the color of their skin, their sexual orientation, their gender identity, their disability status, or where they live. Health equity means that everyone has a fair and just opportunity to be as healthy as possible which requires removing obstacles to health such as ...
The Future of Health Care: The Promise of Clinical Trials in Advancing Cancer Care
... host, in virtual format , our 5th annual forum in Connecticut to examine the current impact and future potential of clinical trials in cancer care, with a focus on disparities and barriers for patient participation. Focus of the Forum This event will examine the importance of cancer ... benefit all patients. Forum participants will include key stakeholders throughout the oncology community, including leaders in life sciences, health care systems, academia, provider groups, patient advocacy, public policy, business, and others. ACS CAN will use this event to help ... closed. You may register day of the event at acscan.windrosemedia.com Speakers Andrea Silber, MD - Assistant Clinical Director for Health Equity and Diversity, Yale Cancer Center Jose DeJesus - Community Health Educator, Yale School of Public Health Pratheesh Sathyan, PhD ...
Cancer Survivors Convene in Hartford, Urge Lawmakers to Expand Access to Biomarker Testing
... in who is benefiting from biomarker testing and biomarker-informed treatment. “Biomarker testing is essential to high-quality, personalized care for many conditions and can be a real gamechanger for many patients, but unfortunately, not everyone who can benefit from biomarker testing is getting it,” said Bryte Johnson, ACS CAN Connecticut director of government relations. “There are significant disparities in health outcomes for Connecticut patients by race, income, and insurance type. Without addressing barriers to care, breakthroughs in personalized treatments could increase these disparities in health outcomes. Already, 20 states have passed similar laws to increase access to comprehensive biomarker testing—and it’s time for ...